Aromatase inhibitors

LT Pill - yellow round

Pill with imprint LT is Yellow, Round and has been identified as Letrozole 2.5 mg. It is supplied by Accord Healthcare Inc.

Letrozole is used in the treatment of Breast Cancer, Metastatic; Breast Cancer, Adjuvant; Breast Cancer and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Letrozole 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Letrozole (Letrozole [ let-roe-zol ])-LT-2.5 mg-Yellow-Round
Letrozole (Letrozole [ let-roe-zol ])-LT-2.5 mg-Yellow-Round
Letrozole (Letrozole [ let-roe-zol ])-LT-2.5 mg-Yellow-Round

Letrozole
Generic Name: letrozole [ let-roe-zol ]
Imprint: LT
Strength: 2.5 mg
Color: Yellow
Size: N/A
Shape: Round
Availability: Prescription only
Drug Class: Aromatase inhibitors Hormones / antineoplastics
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 16729-0034
Inactive Ingredients: Silicon dioxide, Hypromellose 2910 (6 mPa.s), Ferric oxide yellow, Lactose monohydrate, Magnesium stearate, Corn starch, Microcrystalline cellulose, Polyethylene glycol 400, Sodium starch glycolate type A potato, Magnesium silicate, Titanium dioxide,
Latest News
Related Drugs